Lataa...
H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
Abstract Poly(ADP-ribose) polymerase (PARP) inhibitors represent a promising strategy toward the treatment of triple-negative breast cancer (TNBC), which is often associated to genomic instability and/or BRCA mutations. However, clinical outcome is controversial and no benefits have been demonstrate...
Tallennettuna:
| Julkaisussa: | Scientific Reports |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artikkeli |
| Julkaistu: |
Nature Portfolio
2017-08-01
|
| Linkit: | https://doi.org/10.1038/s41598-017-07617-7 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|